Same here GolfR, I didn't get tapped, I expect it was only BoAML that got the opportunity.
Noted also that they are going ahead with clinical trials of SUD01 and SUD03 which will be significantly cheaper than artimist PhIII pre-clinical trials which aren't going to be company funded.
the Company will commence scale-up manufacturing and further clinical studies to confirm the advantages of these two patented oral sprays versus the standard-of-care tablets;
Ann: Suda completes $5.3m capital raising, page-6
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.010(5.71%) |
Mkt cap ! $173.4M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.8¢ | 16.5¢ | $500.8K | 2.930M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1061663 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 92438 | 5 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| ALA (ASX) Chart |